Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| A1068 | A1068_C1 | Mali | 2006 | HIV1 | CRF02_AG | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | 3TC+D4T+EFV | NA |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| M184V | K103N | P225H | I31L, V35T, E40D, K49R, I50V, K122P, S162A, E169K, K173T, Q174E, D177E, I178M, T200A, Q207E, R211K, V245Q, T286A, E291D, V292I, I293V, P294T, S322T, G335D, R356K, M357R, G359S, E370G, A371V, A376S, T377M, T386I, K390R, K395R, T403M, E432D, V435I, R461K, V467I, D471E, Q480H, L491S, K512S, L517I, S519N, Q520L, Q524E, K527G, E529D, A534S |
| >A1068_C1| codons 1-534 PISPIETVPVKLKPGMDGPKVKQWPLTEEKLKALTEICTDMEKEGKISRVGPENPYNTPV FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKNKSVTVLDVGDAYFSVPL DPDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQASMTKILKPFRTENPEMVI YQYVDDLYVGSDLEIGQHRAKIEELREHLLKWGFTTPDKKHQKEHPFLWMGYELHPDKWT VQPIQLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGAKALTDIVTLTEEAE LELAENREILKEPVHGVYYDPTKDLIAEIQKQGQDQWTYQIYQEPFKNLKTGKYAKRRSA HTNDVKQLTGVVQKISMESIVIWGKIPKFRLPIQRETWEAWWMEYWQATWIPEWEFVNTP PLVKLWYQLEKDPIIGAETFYVDGAANRETKLGKAGYVTDKGRQKVISLTETTNQKTELH AIHLALQDSGSEVNIVTDSQYALGIIQAQPDSSESEIVNLIIEELIGKDKVYLS |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| L10I, I13V, L19P, K20I, M36I, R41K, H69K, K70R, L89M |
| >A1068_C1| codons 1-99 PQITLWQRPIVTVKIGGQPIEALLDTGADDTVLEEINLPGKWKPKMIGGIGGFIKVRQYD QILIEICGKRAIGTVLVGPTPVNIIGRNMLTQIGCTLNF |
References
| Author | Title | Citation |
| Sylla, M | Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso. | Antivir Ther, 2008 |